磷酸酶和张力蛋白同源基因诱导激酶1与糖尿病难愈创面修复的研究进展

doi:10.12114/j.issn.1007-9572.2022.0466

摘要/Abstract

摘要： 慢性难愈创面已成为糖尿病严重的并发症之一，且缺乏有效的治疗方法。大量研究证实糖尿病创面修复过程中炎性反应、血管形成及基质重塑等事件均与线粒体功能密切相关。磷酸酶和张力蛋白同源基因诱导激酶1（PINK1）是一种丝氨酸/苏氨酸蛋白激酶，主要定位在线粒体。PINK1参与调控线粒体自噬，保护细胞免受氧化应激损害；另外，其在调控炎性反应、促进脂质代谢等事件中发挥重要作用。PINK1基因突变与帕金森综合征发病密切相关。最近的研究显示PINK1可参与调控2型糖尿病的发生和发展进程。本文综述了PINK1参与糖尿病创面修复机制的最新研究进展，希望通过阐明PINK1调控创面修复的作用机制，发现目前该方面研究尚存的问题。现有研究未能揭示创面修复的不同阶段PINK1参与的分子机制与信号转导过程的时序性和交互作用，且目前仍缺乏PINK1调控糖尿病难愈创面修复的体内研究，期待后期进一步的临床研究为糖尿病难愈创面治疗提供更多思路。

关键词: 糖尿病, 糖尿病难愈创面, 磷酸酶和张力蛋白同源基因诱导激酶1, 创面修复, 综述

Abstract:

Chronic and refractory wounds are serious complications of diabetes mellitus, and have no effective treatments. Numerous studies have confirmed that events such as inflammatory response, angiopoiesis and matrix remodeling are closely related to mitochondrial function during diabetic wound healing. Phosphatase and tensin homologue-induced kinase 1 (PINK1) is a serine/threonine protein kinase primarily located in mitochondria, which is involved in regulating mitochondrial autophagy to protect cells from oxidative stress, and plays an important role in regulating inflammatory responses and promoting lipid metabolism. Mutations in the PINK1 gene are closely related to the onset of Parkinson's syndrome. Recent studies also show that PINK1 may be involved in regulating the development of type 2 diabetes. We gave a description of the mechanism of action of PINK1 in regulating diabetic wound healing after reviewing the latest relevant research, and found that existing studies have failed to reveal the molecular mechanism and the time sequence and interaction of signal transduction process involved by PINK1 in different stages of wound healing. Moreover, there is still a lack of in vivo research on PINK1 regulating the healing of refractory diabetic wounds. It is hoped that further clinical research could provide more ideas for the treatment of refractory diabetic wounds.

Key words: Diabetes mellitus, Diabetic refractory wounds, Phosphatase and tensin homologue gene induced putative kinase 1, Wound repair, Review

杨嘉琪,张培华,黄海丽. 磷酸酶和张力蛋白同源基因诱导激酶1与糖尿病难愈创面修复的研究进展[J]. 中国全科医学, 2023, 26(15): 1909-1915. DOI: 10.12114/j.issn.1007-9572.2022.0466.
YANG Jiaqi,ZHANG Peihua,HUANG Haili. Association of Phosphatase and Tensin Homologue-induced Putative Kinase 1 with Refractory Diabetic Wound Healing: a Review[J]. Chinese General Practice, 2023, 26(15): 1909-1915. DOI: 10.12114/j.issn.1007-9572.2022.0466.

参考文献 79

[1]	AMERICAN DIABETES ASSOCIATION. 11. microvascular complications and foot care：standards of medical care in diabetes-2021[J]. Diabetes Care，2021，44（Suppl 1）：S151-167. DOI：10.2337/dc21-S011.
[2]	SOYOYE D O，ABIODUN O O，IKEM R T，et al. Diabetes and peripheral artery disease：a review[J]. World J Diabetes，2021，12（6）：827-838. DOI：10.4239/wjd.v12.i6.827.
[3]	EISINGER F，PATZELT J，LANGER H F. The platelet response to tissue injury[J]. Front Med （Lausanne），2018，5：317. DOI：10.3389/fmed.2018.00317.
[4]	GOLDBERG S R，DIEGELMANN R F. Basic science of wound healing[J]. Critical Limb Ischemia，2016：131-136. DOI：10.1007/978-3-319-31991-9_14.
[5]	TIAN M，QING C，NIU Y W，et al. The relationship between inflammation and impaired wound healing in a diabetic rat burn model[J]. J Burn Care Res，2016，37（2）：e115-124. DOI：10.1097/BCR.0000000000000171.
[6]	PASTAR I，STOJADINOVIC O，YIN N C，et al. Epithelialization in wound healing：a comprehensive review[J]. Adv Wound Care （New Rochelle），2014，3（7）：445-464. DOI：10.1089/wound.2013.0473.
[7]	ARYA A K，TRIPATHI R，KUMAR S，et al. Recent advances on the association of apoptosis in chronic non healing diabetic wound[J]. World J Diabetes，2014，5（6）：756-762. DOI：10.4239/wjd.v5.i6.756.
[8]	KHALID M，PETROIANU G，ADEM A. Advanced glycation end products and diabetes mellitus：mechanisms and perspectives[J]. Biomolecules，2022，12（4）：542. DOI：10.3390/biom12040542.
[9]	WILGUS T A，ROY S，MCDANIEL J C. Neutrophils and wound repair：positive actions and negative reactions[J]. Adv Wound Care （New Rochelle），2013，2（7）：379-388. DOI：10.1089/wound.2012.0383.
[10]	MOOR A N，VACHON D J，GOULD L J. Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers[J]. Wound Repair Regen，2009，17（6）：832-839. DOI：10.1111/j.1524-475X.2009.00547.x.
[11]	DAS A，GANESH K，KHANNA S，et al. Engulfment of apoptotic cells by macrophages：a role of microRNA-21 in the resolution of wound inflammation[J]. J Immunol，2014，192（3）：1120-1129. DOI：10.4049/jimmunol.1300613.
[12]	PAREDES L C，LUZ R B D S，TOZZI O N，et al. Distinct macrophage phenotypes and redox environment during the fin fold regenerative process in zebrafish[J]. Scand J Immunol，2021，94（2）：e13026. DOI：10.1111/sji.13026.
[13]	DIEGELMANN R F. Excessive neutrophils characterize chronic pressure ulcers[J]. Wound Repair Regen，2003，11（6）：490-495. DOI：10.1046/j.1524-475x.2003.11617.x.
[14]	NWOMEH B C，LIANG H X，DIEGELMANN R F，et al. Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds[J]. Wound Repair Regen，1998，6（2）：127-134. DOI：10.1046/j.1524-475x.1998.60206.x.
[15]	KHANNA S，BISWAS S，SHANG Y L，et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice[J]. PLoS One，2010，5（3）：e9539. DOI：10.1371/journal.pone.0009539.
[16]	WANG Q，ZHU G Y，CAO X Z，et al. Blocking AGE-RAGE signaling improved functional disorders of macrophages in diabetic wound[J]. J Diabetes Res，2017，2017：1428537. DOI：10.1155/2017/1428537.
[17]	AITCHESON S M，FRENTIU F D，HURN S E，et al. Skin wound healing：normal macrophage function and macrophage dysfunction in diabetic wounds[J]. Molecules，2021，26（16）：4917. DOI：10.3390/molecules26164917.
[18]	PINTO-JUNIOR D C，SILVA K S，MICHALANI M L，et al. Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression[J]. Sci Rep，2018，8（1）：8109. DOI：10.1038/s41598-018-26482-6.
[19]	LARTIGUE L，FAUSTIN B. Mitochondria：metabolic regulators of innate immune responses to pathogens and cell stress[J]. Int J Biochem Cell Biol，2013，45（9）：2052-2056. DOI：10.1016/j.biocel.2013.06.014.
[20]	ROSSIGNOL R，LETELLIER T，MALGAT M，et al. Tissue variation in the control of oxidative phosphorylation：implication for mitochondrial diseases[J]. Biochem J，2000，347（Pt 1）：45-53.
[21]	GÓMEZ-VALADES A G，GONZALEZ-FRANQUESA A，GAMA-PEREZ P，et al. Emerging concepts in diabetes：mitochondrial dynamics and glucose homeostasis[J]. Curr Diabetes Rev，2017，13（4）：370-385. DOI：10.2174/1573399812666151012115229.
[22]	CHOO H J，KIM J H，KWON O B，et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice[J]. Diabetologia，2006，49（4）：784-791. DOI：10.1007/s00125-006-0170-2.
[23]	PINTI M V，FINK G K，HATHAWAY Q A，et al. Mitochondrial dysfunction in type 2 diabetes mellitus：an organ-based analysis[J]. Am J Physiol Endocrinol Metab，2019，316（2）：E268-285. DOI：10.1152/ajpendo.00314.2018.
[24]	RIEUSSET J. Contribution of mitochondria and endoplasmic Reticulum dysfunction in insulin resistance：distinct or interrelated roles? [J]. Diabetes Metab，2015，41（5）：358-368. DOI：10.1016/j.diabet.2015.02.006.
[25]	CHATTOPADHYAY M，KHEMKA V K，CHATTERJEE G，et al. Enhanced ROS production and oxidative damage in subcutaneous white adipose tissue mitochondria in obese and type 2 diabetes subjects[J]. Mol Cell Biochem，2015，399（1/2）：95-103. DOI：10.1007/s11010-014-2236-7.
[26]	ANDERSON E J，LUSTIG M E，BOYLE K E，et al. Mitochondrial H₂O₂ emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans[J]. J Clin Invest，2009，119（3）：573-581. DOI：10.1172/JCI37048.
[27]	OTT M，GOGVADZE V，ORRENIUS S，et al. Mitochondria，oxidative stress and cell death[J]. Apoptosis，2007，12（5）：913-922. DOI：10.1007/s10495-007-0756-2.
[28]	MURPHY M P. How mitochondria produce reactive oxygen species[J]. Biochem J，2009，417（1）：1-13. DOI：10.1042/BJ20081386.
[29]	ZHANG B Y，PAN C Y，FENG C，et al. Role of mitochondrial reactive oxygen species in homeostasis regulation[J]. Redox Rep，2022，27（1）：45-52. DOI：10.1080/13510002.2022.2046423.
[30]	KOENIG A，BUSKIEWICZ-KOENIG I A. Redox activation of mitochondrial DAMPs and the metabolic consequences for development of autoimmunity[J]. Antioxid Redox Signal，2022，36（7/8/9）：441-461. DOI：10.1089/ars.2021.0073.
[31]	BRAND M D，AFFOURTIT C，ESTEVES T C，et al. Mitochondrial superoxide：production，biological effects，and activation of uncoupling proteins[J]. Free Radic Biol Med，2004，37（6）：755-767. DOI：10.1016/j.freeradbiomed.2004.05.034.
[32]	KRYSKO D V，AGOSTINIS P，KRYSKO O，et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation[J]. Trends Immunol，2011，32（4）：157-164. DOI：10.1016/j.it.2011.01.005.
[33]	XIE L L，SHI F，TAN Z Q，et al. Mitochondrial network structure homeostasis and cell death[J]. Cancer Sci，2018，109（12）：3686-3694. DOI：10.1111/cas.13830.
[34]	GOTTLIEB R A，PIPLANI H，SIN J，et al. At the heart of mitochondrial quality control：many roads to the top[J]. Cell Mol Life Sci，2021，78（8）：3791-3801. DOI：10.1007/s00018-021-03772-3.
[35]	MIZUSHIMA N，KOMATSU M. Autophagy：renovation of cells and tissues[J]. Cell，2011，147（4）：728-741. DOI：10.1016/j.cell.2011.10.026.
[36]	HASSON S A，KANE L A，YAMANO K，et al. High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy[J]. Nature，2013，504（7479）：291-295. DOI：10.1038/nature12748.
[37]	ROJANSKY R，CHA M Y，CHAN D C. Elimination of paternal mitochondria in mouse embryos occurs through autophagic degradation dependent on PARKIN and MUL1[J]. eLife，2016，5：e17896. DOI：10.7554/eLife.17896.
[38]	GAN Z Y，CALLEGARI S，COBBOLD S A，et al. Activation mechanism of PINK1[J]. Nature，2022，602（7896）：328-335. DOI：10.1038/s41586-021-04340-2.
[39]	NARENDRA D，TANAKA A，SUEN D F，et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy[J]. J Cell Biol，2008，183（5）：795-803. DOI：10.1083/jcb.200809125.
[40]	MCWILLIAMS T G，MUQIT M M. PINK1 and Parkin：emerging themes in mitochondrial homeostasis[J]. Curr Opin Cell Biol，2017，45：83-91. DOI：10.1016/j.ceb.2017.03.013.
[41]	LAZAROU M，SLITER D A，KANE L A，et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy[J]. Nature，2015，524（7565）：309-314. DOI：10.1038/nature14893.
[42]	ARENA G，GELMETTI V，TOROSANTUCCI L，et al. PINK1 protects against cell death induced by mitochondrial depolarization，by phosphorylating Bcl-xL and impairing its pro-apoptotic cleavage[J]. Cell Death Differ，2013，20（7）：920-930. DOI：10.1038/cdd.2013.19.
[43]	ARENA G，VALENTE E M. PINK1 in the limelight：multiple functions of an eclectic protein in human health and disease[J]. J Pathol，2017，241（2）：251-263. DOI：10.1002/path.4815.
[44]	CHOI J，RAVIPATI A，NIMMAGADDA V，et al. Potential roles of PINK1 for increased PGC-1α-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes[J]. Mitochondrion，2014，18：41-48. DOI：10.1016/j.mito.2014.09.005.
[45]	MARTELLA G，MADEO G，MALTESE M，et al. Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice[J]. Neurobiol Dis，2016，91：21-36. DOI：10.1016/j.nbd.2015.12.020.
[46]	AKUNDI R S，ZHI L T，SULLIVAN P G，et al. Shared and cell type-specific mitochondrial defects and metabolic adaptations in primary cells from PINK1-deficient mice[J]. Neurodegener Dis，2013，12（3）：136-149. DOI：10.1159/000345689.
[47]	KOH H，CHUNG J. PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity[J]. Mol Cells，2012，34（1）：7-13. DOI：10.1007/s10059-012-0100-8.
[48]	VALENTE E M，ABOU-SLEIMAN P M，CAPUTO V，et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1[J]. Science，2004，304（5674）：1158-1160. DOI：10.1126/science.1096284.
[49]	DEAS E，PIIPARI K，MACHHADA A，et al. PINK1 deficiency in β-cells increases basal insulin secretion and improves glucose tolerance in mice[J]. Open Biol，2014，4：140051. DOI：10.1098/rsob.140051.
[50]	CANG X M，WANG X H，LIU P L，et al. PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways[J]. Biochem Biophys Res Commun，2016，478（1）：431-438. DOI：10.1016/j.bbrc.2016.07.004.
[51]	BHANSALI S，BHANSALI A，WALIA R，et al. Alterations in mitochondrial oxidative stress and mitophagy in subjects with prediabetes and type 2 diabetes mellitus[J]. Front Endocrinol （Lausanne），2017，8：347. DOI：10.3389/fendo.2017.00347.
[52]	LIU K，ZHAO E P，ILYAS G，et al. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization[J]. Autophagy，2015，11（2）：271-284. DOI：10.1080/15548627.2015.1009787.
[53]	LIN Q S，LI S，JIANG N，et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation[J]. Redox Biol，2019，26：101254. DOI：10.1016/j.redox.2019.101254.
[54]	ZHANG Y，SAULER M，SHINN A S，et al. Endothelial PINK1 mediates the protective effects of NLRP3 deficiency during lethal oxidant injury[J]. J Immunol，2014，192（11）：5296-5304. DOI：10.4049/jimmunol.1400653.
[55]	QASIM W，LI Y，SUN R M，et al. PTEN-induced kinase 1-induced dynamin-related protein 1 Ser637 phosphorylation reduces mitochondrial fission and protects against intestinal ischemia reperfusion injury[J]. World J Gastroenterol，2020，26（15）：1758-1774. DOI：10.3748/wjg.v26.i15.1758.
[56]	MURATA H，TAKAMATSU H，LIU S L，et al. NRF2 regulates PINK1 expression under oxidative stress conditions[J]. PLoS One，2015，10（11）：e0142438. DOI：10.1371/journal.pone.0142438.
[57]	MEI Y，ZHANG Y R，YAMAMOTO K，et al. FOXO3a-dependent regulation of Pink1 （Park6） mediates survival signaling in response to cytokine deprivation[J]. Proc Natl Acad Sci USA，2009，106（13）：5153-5158. DOI：10.1073/pnas.0901104106.
[58]	JULIANA C，FERNANDES-ALNEMRI T，KANG S，et al. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation[J]. J Biol Chem，2012，287（43）：36617-36622. DOI：10.1074/jbc.M112.407130.
[59]	SHIMADA K，CROTHER T R，KARLIN J，et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis[J]. Immunity，2012，36（3）：401-414. DOI：10.1016/j.immuni.2012.01.009.
[60]	BAUERNFEIND F，BARTOK E，RIEGER A，et al. Cutting edge：reactive oxygen species inhibitors block priming，but not activation，of the NLRP3 inflammasome[J]. J Immunol，2011，187（2）：613-617. DOI：10.4049/jimmunol.1100613.
[61]	SWANSON K V，DENG M，TING J P Y. The NLRP3 inflammasome：molecular activation and regulation to therapeutics[J]. Nat Rev Immunol，2019，19（8）：477-489. DOI：10.1038/s41577-019-0165-0.
[62]	KANKI T，FURUKAWA K，YAMASHITA S I. Mitophagy in yeast：molecular mechanisms and physiological role[J]. Biochim Biophys Acta，2015，1853（10 Pt B）：2756-2765. DOI：10.1016/j.bbamcr.2015.01.005.
[63]	ZHOU R B，YAZDI A S，MENU P，et al. A role for mitochondria in NLRP3 inflammasome activation[J]. Nature，2011，469（7329）：221-225. DOI：10.1038/nature09663.
[64]	MOUTON-LIGER F，ROSAZZA T，SEPULVEDA-DIAZ J，et al. Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop[J]. Glia，2018，66（8）：1736-1751. DOI：10.1002/glia.23337.
[65]	XU Y，TANG Y B，LU J W，et al. PINK1-mediated mitophagy protects against hepatic ischemia/reperfusion injury by restraining NLRP3 inflammasome activation[J]. Free Radic Biol Med，2020，160：871-886. DOI：10.1016/j.freeradbiomed.2020.09.015.
[66]	KANG R，ZENG L，XIE Y C，et al. A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal Sepsis[J]. Autophagy，2016，12（12）：2374-2385. DOI：10.1080/15548627.2016.1239678.
[67]	ZHANG J，HUANG W G，HE Q K，et al. PINK1/PARK2 dependent mitophagy effectively suppresses NLRP3 inflammasome to alleviate acute pancreatitis[J]. Free Radic Biol Med，2021，166：147-164. DOI：10.1016/j.freeradbiomed.2021.02.019.
[68]	LOWELL B B，SHULMAN G I. Mitochondrial dysfunction and type 2 diabetes[J]. Science，2005，307（5708）：384-387. DOI：10.1126/science.1104343.
[69]	ZHANG S R，GAO Y，WANG J A. Advanced glycation end products influence mitochondrial fusion-fission dynamics through RAGE in human aortic endothelial cells[J]. Int J Clin Exp Pathol，2017，10（7）：8010-8022.
[70]	WU W W，XU H，WANG Z M，et al. PINK1-parkin-mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury[J]. PLoS One，2015，10（7）：e0132499. DOI：10.1371/journal.pone.0132499.
[71]	YANG J，SUN M J，CHENG R，et al. Pitavastatin activates mitophagy to protect EPC proliferation through a calcium-dependent CAMK1-PINK1 pathway in atherosclerotic mice[J]. Commun Biol，2022，5（1）：124. DOI：10.1038/s42003-022-03081-w.
[72]	XI J X，RONG Y Z，ZHAO Z F，et al. Scutellarin ameliorates high glucose-induced vascular endothelial cells injury by activating PINK1/Parkin-mediated mitophagy[J]. J Ethnopharmacol，2021，271：113855. DOI：10.1016/j.jep.2021.113855.
[73]	ZHANG Y K，WANG S Y，CHEN X，et al. Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1/Parkin-dependent mitophagy[J]. Mol Cell Endocrinol，2022，545：111560. DOI：10.1016/j.mce.2022.111560.
[74]	XIANG J，ZHANG C L，DI T T，et al. Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells[J]. Bioengineered，2022，13（2）：3486-3502. DOI：10.1080/21655979.2022.2026552.
[75]	FAN Y Z，CHENG Z L，MAO L J，et al. PINK1/TAX1BP1-directed mitophagy attenuates vascular endothelial injury induced by copper oxide nanoparticles[J]. J Nanobiotechnology，2022，20（1）：149. DOI：10.1186/s12951-022-01338-4.
[76]	KLINKENBERG M，THUROW N，GISPERT S，et al. Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress[J]. Neuroscience，2010，166（2）：422-434. DOI：10.1016/j.neuroscience.2009.12.068.
[77]	QIANG L，YANG S，CUI Y H，et al. Keratinocyte autophagy enables the activation of keratinocytes and fibroblastsand facilitates wound healing[J]. Autophagy，2021，17（9）：2128-2143. DOI：10.1080/15548627.2020.1816342.
[78]	MIGNEAULT F，HÉBERT M J. Autophagy，tissue repair，and fibrosis：a delicate balance[J]. Matrix Biol，2021，100/101：182-196. DOI：10.1016/j.matbio.2021.01.003.
[79]	ZHU W Z，YUAN Y J，LIAO G N，et al. Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy[J]. Cell Death Dis，2018，9（8）：837. DOI：10.1038/s41419-018-0861-x.